There is no regulator, licensing board or veterinary association that certifies a joint supplement as "vet recommended". It is a marketing phrase any brand can print, and it usually means a survey found some vets who mention the product, not that the finished product was tested in dogs. So the useful question is not which joint supplement is vet recommended, but what a veterinarian actually checks before recommending one: the ingredient's own trial evidence, what independent quality assurance the maker can show, whether the label discloses milligrams per serving, and whether the ingredient list matches what the objective research supports. Whichever product you land on, check it against this list, including Pure Majesty Pets Hip & Joint Chews (A$80, free worldwide shipping to Australia, duties and GST prepaid).
This guide gives you that checklist, then applies it honestly, including to our own formula.
What "vet recommended" actually means on an Australian label (almost nothing)
Veterinary products in Australia are overseen by the Australian Pesticides and Veterinary Medicines Authority (APVMA). According to its published guidance, nutritional supplements that make no disease-cure claims can be "Excluded Nutritional or Digestive" products that do not need registration, and an approved quality assurance system (APVMA GMP, FeedSafe, FAMI-QS or equivalent) and set label fields apply; supplements making therapeutic claims, or containing nutrients above normal daily requirements, need registration as complementary animal health products (APVMA: excluded products; APVMA: complementary products). Nothing in that guidance defines "vet recommended". That phrase is generally based on brand-awareness surveys of practising vets, not on head-to-head clinical outcomes. A brand can be genuinely well known among vets, as the overseas products Cosequin and Dasuquin are (registered trademarks of Nutramax Laboratories; Pure Majesty Pets is not affiliated with them), and still not be the formula best matched to what the objective evidence shows.
The gap is not hypothetical. Writing in Frontiers in Veterinary Science in 2024, Kampa and colleagues opened their trial by noting that "with little to no regulation of the supplement markets and a paucity of quality information regarding clinical utility of individual marketed supplements, it is difficult for veterinarians to provide any evidence-based recommendations to owners" (PMID 39450405). That is the real state of the category, stated by the researchers running the trials.
The 5-point audit a vet-recommended label should survive
- Independent quality assurance. Look for evidence of an approved quality system and batch testing, such as certificates of analysis. It is a quality signal, not proof the product works.
- Milligrams per serving, not "proprietary blend". If you cannot compute the daily milligram dose for your dog's weight, you cannot compare the product to any published trial.
- Ingredients with dog trials, not human or rodent ones. Ask whether the evidence cited was generated in dogs with naturally occurring osteoarthritis.
- Objective outcome measures. Force-plate peak vertical force (PVF) measures how much weight the dog actually puts on the limb. Owner questionnaires alone are highly placebo-sensitive.
- A named contact and lot traceability. If nobody answers a question about a lot number, no badge on the front matters.
What the objective evidence ranks first (and it is not glucosamine)
This is where most "vet recommended" listicles quietly go wrong. When trials measure force plates rather than owner impressions, the ingredient ranking changes.
The largest synthesis to date, a 2022 systematic review and meta-analysis of 72 trials by Barbeau-Grégoire and colleagues in International Journal of Molecular Sciences, reported "an evident clinical analgesic efficacy for omega-3-enriched diets, omega-3 supplements and cannabidiol", "a weak efficacy of collagen" and "a very marked non-effect of chondroitin-glucosamine nutraceuticals" (PMID 36142319). A decade earlier, Vandeweerd and colleagues in the Journal of Veterinary Internal Medicine reached a compatible conclusion: evidence strength was low for all nutraceuticals "except for omega-3 fatty acid in dogs" (PMID 22404506).
The force-plate trials agree. In a block-randomised, double-blinded, placebo-controlled study of 75 dogs with hip osteoarthritis, glucosamine and chondroitin sulfate produced a PVF change of −0.05 ± 6.34 at four weeks, statistically indistinguishable from placebo, while green-lipped mussel-based marine compounds (PCSO-524, EAB-277) and carprofen all improved significantly (PMID 36816197). A 2024 follow-up of 101 dogs found EAB-277 and meloxicam significantly better than placebo on PVF at six weeks, while a Biota orientalis product did not differ from placebo at all (PMID 39450405).
| Ingredient | Best available dog evidence | Strength |
|---|---|---|
| Omega-3 (EPA/DHA) | 78-dog randomised double-blind placebo-controlled trial at ~69 mg EPA+DHA/kg/day improved discomfort, lameness and joint scores by day 84 (PMID 27269707); ranked highest in the 2022 meta-analysis | Strongest |
| Green-lipped mussel (± krill) | Two force-plate trials showing significant PVF gains vs placebo, comparable to NSAIDs (PMID 36816197, 39450405) | Strong |
| UC-II undenatured type II collagen | 76-dog randomised study: LOAD score fell 31.4% on UC-II vs untreated controls (PMID 35853328); crossover trial with Boswellia improved owner-rated mobility from week 4 (PMID 39475935) | Moderate |
| Glucosamine + chondroitin alone | No PVF benefit over placebo at 4 or 6 weeks (PMID 36816197); "marked non-effect" in the 2022 meta-analysis; a 15-dog working-dog study also found no group-level benefit (PMID 29525231) | Weak on objective measures |
Read that table again, because it reframes the whole category: the two ingredients most joint chews are built around are the two with the weakest objective data. They are well tolerated and they remain a reasonable cartilage-support base, but a supplement that is only glucosamine and chondroitin is built on the softest part of the evidence. If you want the ingredient detail, see our breakdown of glucosamine chondroitin for dogs and the trial record for green-lipped mussel for dogs.
What is on Australian shelves?
Run the same audit on what you can buy locally. When we checked on 7 October 2026: PAW by Blackmores Osteocare Joint Health Chews were A$41.99 for 300 g at Petbarn; Vetalogica Canine Joint Support was A$33.99 for 120 chews at National Pharmacies; 4CYTE Canine was A$60.99 for 50 g at Pet Circle; and PAW Osteosupport (Perna128 green-lipped mussel, 500 mg capsules) was A$96.21 for 150 capsules at Petstock. Prices move often, so recheck before buying. The point is not that any of these fails the audit; it is that you should put each through the same five questions, whichever shop you use.
How our formula scores on the same audit
We will not claim a veterinary endorsement we cannot document. What we can show is ingredient alignment. Pure Majesty Pets Hip & Joint Chews carry 18 named active ingredients rather than the two or three that define the mainstream chew, and the additions include ingredients the objective trials favour: green-lipped mussel and UC-II undenatured type II collagen sit alongside the glucosamine HCl, chondroitin sulfate and MSM base, with hyaluronic acid, eggshell membrane, turmeric extract, Boswellia serrata and ginger extract behind them.
18 named actives in one daily chew – A$80
Free worldwide shipping: ships to Australia with duties and GST prepaid (DDP), nothing to pay on delivery.
The honest caveat, stated plainly: our per-chew milligram breakdown is not published on the product page, which means you cannot yet line our chew up against the exact doses used in the trials above. By our own point 2, that is a gap, and we would rather name it than paper over it. The chew's page also does not list omega-3 as a separate active, so if your vet recommends fish oil, that is a separate purchase. What you can verify is the composition and format, and you should follow the weight-based directions on the label. For dogs who refuse chews, liquid glucosamine for dogs (A$47) delivers the glucosamine, chondroitin and MSM core already dissolved; both formats sit in the dog joint and hip supplements collection.
What a supplement will not do
No supplement replaces a diagnosis. Limping, yelping, a sudden refusal to bear weight, or a joint that is hot and swollen are veterinary appointments, not shopping decisions. A torn cruciate ligament, an infection and osteoarthritis all look like "stiffness" from the sofa. Talk to your veterinarian first if your dog is on an NSAID, has kidney or liver disease, is pregnant, or has a shellfish sensitivity (green-lipped mussel is a shellfish). Know the signs of arthritis in dogs so you catch the pattern early, and remember that weight control and controlled exercise remain the two highest-yield interventions in canine osteoarthritis: no chew outperforms taking two kilograms off an overweight Labrador. In summer, keep walks to the cooler ends of the day and use the five-second pavement hand test, as the RSPCA Australia advises (RSPCA Australia heat advice).
A realistic timeline
- Weeks 1–2: expect nothing measurable. Owner-perceived change this early is usually placebo or a good weather week.
- Weeks 4–6: the window in which the force-plate trials detected real change on the ingredients that worked. Film your dog on the same stairs at week 0 and week 6, because video beats memory.
- Weeks 8–12: if nothing has shifted and dosing has been consistent and weight-appropriate, the formula is not doing the job. Change it or reassess with your vet rather than continuing on hope.
Frequently asked questions
Is there an officially vet-recommended joint supplement for dogs?
No. No veterinary body certifies joint supplements. "Vet recommended" and "#1 veterinarian recommended" are marketing claims usually derived from brand-awareness surveys, not from head-to-head clinical trials of the finished product.
Do vets recommend glucosamine for dogs?
Many do, and it is well tolerated, but the objective evidence is weak. A 2022 meta-analysis reported a "marked non-effect" of glucosamine-chondroitin nutraceuticals on pain (PMID 36142319), and a force-plate trial found no significant weight-bearing improvement over placebo (PMID 36816197). Treat it as a base ingredient, not the whole formula.
What has the strongest evidence for canine joint pain?
Omega-3 fatty acids (EPA/DHA) have the most consistent support, followed by green-lipped mussel preparations, both shown in randomised placebo-controlled trials. Weight management and controlled exercise remain foundational.
How do I check a brand's quality claims myself?
Look for evidence of independent quality assurance and batch testing, a published milligram breakdown per serving, dog-specific trial citations, and a lot number the company will discuss with you. If three of the four are missing, the "vet recommended" badge is decoration.
Keep reading
Compare formulas side by side in our guide to the best joint supplements for dogs, see how an overseas category leader holds up in our Cosequin for dogs review, or start with the fundamentals in the dog joint and hip health complete guide. Older dogs have their own considerations: see the best senior dog joint supplement guide. Ready to try an 18-active formula? Order the Hip & Joint Chews with free worldwide shipping, duties and GST prepaid.
Sources
- Barbeau-Grégoire M, et al. A 2022 Systematic Review and Meta-Analysis of Enriched Therapeutic Diets and Nutraceuticals in Canine and Feline Osteoarthritis. Int J Mol Sci. 2022;23(18):10384. PMID 36142319.
- Vandeweerd JM, et al. Systematic review of efficacy of nutraceuticals to alleviate clinical signs of osteoarthritis. J Vet Intern Med. 2012;26(3):448-56. PMID 22404506.
- Kampa N, et al. Study of the effectiveness of glucosamine and chondroitin sulfate, marine based fatty acid compounds (PCSO-524 and EAB-277), and carprofen for the treatment of dogs with hip osteoarthritis. Front Vet Sci. 2023;10:1033188. PMID 36816197.
- Kampa N, et al. Evaluation of the comparative efficacy of green lipped mussel plus krill oil extracts (EAB-277), Biota orientalis extracts or NSAIDs. Front Vet Sci. 2024;11:1464549. PMID 39450405.
- Mehler SJ, et al. A prospective, randomized, double blind, placebo-controlled evaluation of the effects of EPA and DHA in dogs with osteoarthritis. Prostaglandins Leukot Essent Fatty Acids. 2016;109:1-7. PMID 27269707.
- Stabile M, et al. Evaluation of clinical efficacy of undenatured type II collagen supplementation compared to cimicoxib. Res Vet Sci. 2022;151:27-35. PMID 35853328.
- Stabile M, et al. Effects of a feed supplement containing UC-II and Boswellia Serrata in mild/moderate mobility disorders in dogs. PLoS One. 2024;19(10):e0305697. PMID 39475935.
- Alves JC, et al. Effect of an Oral Joint Supplement When Compared to Carprofen in the Management of Hip Osteoarthritis in Working Dogs. Top Companion Anim Med. 2017;32(4):126-129. PMID 29525231.
Educational information only, not veterinary advice. These statements have not been assessed by the APVMA, and this product is not intended to replace veterinary diagnosis or treatment of any condition. Always consult your veterinarian before starting a supplement, particularly if your dog takes medication or has a diagnosed condition. Cosequin and Dasuquin are registered trademarks of Nutramax Laboratories; Pure Majesty Pets is not affiliated with Nutramax.